.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
Novartis
Baxter
Federal Trade Commission
Johnson and Johnson
UBS
Express Scripts
Queensland Health
Dow

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076980

« Back to Dashboard
NDA 076980 describes MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Glenmark Pharms, Heritage Pharms Inc, Teva, and Chartwell Rx, and is included in four NDAs. It is available from four suppliers. Additional details are available on the MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.

Summary for NDA: 076980

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 076980

Ingredient-typeThiazides
Mechanism of ActionAngiotensin-converting Enzyme Inhibitors
Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 076980

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL 076980 ANDA Teva Pharmaceuticals USA, Inc. 0093-5213 0093-5213-01 100 TABLET, FILM COATED in 1 BOTTLE (0093-5213-01)
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL 076980 ANDA Teva Pharmaceuticals USA, Inc. 0093-5214 0093-5214-01 100 TABLET, FILM COATED in 1 BOTTLE (0093-5214-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG;7.5MG
Approval Date:Mar 7, 2007TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;15MG
Approval Date:Mar 7, 2007TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG;15MG
Approval Date:Mar 7, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Moodys
Merck
Boehringer Ingelheim
UBS
Cipla
Baxter
Argus Health
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot